ProtekAI Overview
- Founded
-
2010
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
ProtekAI General Information
Description
Developer of proteins intended for the life science industry. The company is engaged in the research and development of a de novo fluorescent protein extracted from the marine organism Physalia (Portuguese man-of-war), enabling the medical and scientific community to support diagnostic and research applications.
Contact Information
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Drug Discovery
Primary Office
- 7192 Kalanianaole Highway
- Suite A143a, Number 255
- Honolulu, HI 96825
- United States
ProtekAI Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 01-Jun-2018 | 00000 | Completed | Out of Business | ||
| 2. Accelerator/Incubator | 00000 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 07-Dec-2010 | $100K | $100K | 00000 | Completed | Generating Revenue |
ProtekAI Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed | 0,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |